|
⚲
|
| Keyboard |
| Daniell Richard
✚
|
|
|---|---|
| CIK # | 0001726096 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001726096] | |
| 4 | [0001726096] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Teva Pharmaceutical Industries Ltd | |
| Daniell Richard |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2026-03-05 | Option exercise | 17,295 | ||
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2026-03-05 | Sell | 17,295 | $31.67 | 547,733 |
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2026-03-05 | Option exercise | 17,295 | $0.00 | |
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2026-03-04 | Option exercise | 20,461 | $0.00 | |
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2026-03-04 | Option exercise | 20,461 | ||
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2026-03-04 | Sell | 20,461 | $32.46 | 664,164 |
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2026-03-04 | Option exercise | 33,512 | ||
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2026-03-04 | Sell | 37,372 | $32.95 | 1,231,407 |
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2026-03-04 | Sell | 33,512 | $32.46 | 1,087,800 |
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2026-03-04 | Option exercise | 33,512 | $0.00 | |
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2026-03-04 | Grant | 33,424 | $0.00 | |
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2026-03-03 | Option exercise | 62,250 | $0.00 | |
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2026-03-03 | Option exercise | 62,250 | ||
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2026-03-03 | Sell | 66,735 | $32.36 | 2,159,545 |
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2026-03-03 | Option exercise | 141,478 | ||
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2026-03-03 | Sell | 62,250 | $32.36 | 2,014,410 |
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2026-03-03 | Option exercise | 141,478 | $0.00 | |
|
Teva Pharmaceutical Industries Ltd TEVA
Restricted Share Units · derivative
|
2026-01-27 | Grant | 141,478 | $0.00 | |
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2025-12-09 | Option exercise | 100,457 | $18.61 | 1,869,505 |
|
Teva Pharmaceutical Industries Ltd TEVA
Ordinary Shares
|
2025-12-09 | Option exercise | 15,011 | $16.99 | 255,037 |
| showing 20 of 158 most recent transactions | |||||